News
Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...
5h
The Scarborough News on MSNScarborough man raises over £1600 for charity by walking the Cinder Track
John Maskill, 89, decided to walk the Cinder Track after losing his wife to Progressive Supranuclear Palsy (PSP) in March.
Amylyx is a high-risk biotech targeting rare diseases with strong cash reserves. Key trials soon may drive a 40% stock upside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results